MCM
GILD icon

Morton Capital Management’s Gilead Sciences GILD Stock Holding History

Morton Capital Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$238K Buy
1,883
+71
+4% +$9.36K 0.03% 138
2026
Q1 		$253K Buy
1,812
+149
+9% +$20.9K 0.04% 111
2025
Q4 		$204K Buy
+1,663
New +$202K 0.03% 130

Other funds holding GILD

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return

Morton Capital Management's GILD Position: Q2 2026 in Review

Morton Capital Management increased its Gilead Sciences (GILD) stake by 3.9% in Q2 2026, buying an estimated $9.36K and bringing the position to 1,883 shares worth $238K. The position accounts for 0.03% of the portfolio, ranked #138.

Morton Capital Management first reported a position in GILD in Q4 2025 and has held it in 3 quarters since. The position peaked at $253K in Q1 2026. 617 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Morton Capital Management held 1,883 shares of Gilead Sciences worth $238K as of Q2 2026.
  • Morton Capital Management bought 71 Gilead Sciences shares in Q2 2026, an estimated $9.36K.
  • Gilead Sciences made up 0.03% of Morton Capital Management's portfolio in Q2 2026, its #138 holding.
  • Morton Capital Management first reported a position in Gilead Sciences in Q4 2025 and has held it in 3 quarters since.
  • Morton Capital Management's Gilead Sciences position peaked at $253K in Q1 2026.
  • 617 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Morton Capital Management's 13F filing for Q2 2026, filed 23 Jul 2026.